Spectrascience Historical Balance Sheet
Trend analysis of Spectrascience New balance sheet accounts such as Cash of 3 K, Other Assets of 88.4 K, Inventory of 77.5 K or Other Current Assets of 0.0 provides information on Spectrascience New's total assets, liabilities, and equity, which is the actual value of Spectrascience New to its prevalent stockholders. By breaking down trends over time using Spectrascience New balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Spectrascience New latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Spectrascience New is a good buy for the upcoming year.
Spectrascience New Inventory |
|
Spectrascience |
About Spectrascience Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Spectrascience New at a specified time, usually calculated after every quarter, six months, or one year. Spectrascience New Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Spectrascience New and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Spectrascience currently owns. An asset can also be divided into two categories, current and non-current.
Spectrascience New Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Spectrascience New assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Spectrascience New books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Spectrascience New balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Spectrascience New are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Accounts Payable
An accounting item on the balance sheet that represents Spectrascience New obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Spectrascience New are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most accounts from Spectrascience New's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Spectrascience New current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Spectrascience New. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For information on how to trade Spectrascience Stock refer to our How to Trade Spectrascience Stock guide.At present, Spectrascience New's Total Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Accounts Payable is expected to grow to about 1.6 M, whereas Total Stockholder Equity is projected to grow to (9 M).
| 2015 | 2016 | 2024 | 2025 (projected) | Other Current Liabilities | 620.3K | 819.9K | 942.9K | 990.1K | Total Assets | 1.9M | 1.4M | 1.6M | 1.5M |
Spectrascience New balance sheet Correlations
Click cells to compare fundamentals
Spectrascience New Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Spectrascience New. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For information on how to trade Spectrascience Stock refer to our How to Trade Spectrascience Stock guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spectrascience New. If investors know Spectrascience will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spectrascience New listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Spectrascience New is measured differently than its book value, which is the value of Spectrascience that is recorded on the company's balance sheet. Investors also form their own opinion of Spectrascience New's value that differs from its market value or its book value, called intrinsic value, which is Spectrascience New's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spectrascience New's market value can be influenced by many factors that don't directly affect Spectrascience New's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spectrascience New's value and its price as these two are different measures arrived at by different means. Investors typically determine if Spectrascience New is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spectrascience New's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.